Media Gallery Test
Total Posts: 57 Pages: 5 Current Page: 1
1 2 3 4 5 Next
IIVS News: IIVS 2023 Impact Report
I am happy to present to you the Institute for In Vitro Sciences’ (IIVS) 2023…
IIVS News: IIVS Partners with SkynFuture to Further In Vitro Research Techniques
IIVS is pleased to announce a partnership with SkynFuture, a cosmetics and skincare brand within…
IIVS News: IIVS Acquires Licenses to Work with DEA Schedule I Materials
IIVS is pleased to announce that our lab has acquired the necessary State and Federal…
IIVS News: IIVS and Toxys Enter Into Agreement to Offer ToxTracker® for In Vitro Genetic Toxicity Evaluation
The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement…
IIVS News: IIVS Toxicologist Presents on Safety Testing in Latin America
IIVS Toxicologist Dr. Argel Islas-Robles participated last week as speaker on the “In Vitro Science…
IIVS News: IIVS Posters and Presentations at the 11th of the World Congress on Alternatives and Animal Use in the Life Sciences - Check out our activities!
IIVS News: IIVS Co-Publishes Article on Ocular Animal Model Alternatives
The human eye may be exposed to chemicals through various situations, such as accidental splashing…
IIVS News: IIVS to collaborate with RIFM to develop non-animal technologies for respiratory allergy
The Institute for In Vitro Sciences (IIVS) and the Research Institute for Fragrance Materials (RIFM)…
IIVS News: Validation of the 3D RSMN Assay
IIVS is excited to have taken part in the validation of the Reconstructed Skin Micronucleus…
IIVS News: IIVS e-News – October 2020
IIVS is pleased to announce that Allison Hilberer will participate in the OECD Test Guidelines…
IIVS News: IIVS, RIFM and Shiseido Partner to Transfer Non-animal Photosafety Tests
The Institute for In Vitro Sciences (IIVS) has entered into an agreement with Shiseido and…
IIVS News: Webinar : Use of Non-animal Skin Sensitization Methods
A recorded webinar on the “Use of Non-animal Skin Sensitization Methods” by IIVS’s Hans Raabe…
1 2 3 4 5 Next
1 2 3 4 5 Next
IIVS News: IIVS 2023 Impact Report
I am happy to present to you the Institute for In Vitro Sciences’ (IIVS) 2023…
IIVS News: IIVS Partners with SkynFuture to Further In Vitro Research Techniques
IIVS is pleased to announce a partnership with SkynFuture, a cosmetics and skincare brand within…
IIVS News: IIVS Acquires Licenses to Work with DEA Schedule I Materials
IIVS is pleased to announce that our lab has acquired the necessary State and Federal…
IIVS News: IIVS and Toxys Enter Into Agreement to Offer ToxTracker® for In Vitro Genetic Toxicity Evaluation
The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement…
IIVS News: IIVS Toxicologist Presents on Safety Testing in Latin America
IIVS Toxicologist Dr. Argel Islas-Robles participated last week as speaker on the “In Vitro Science…
IIVS News: IIVS Posters and Presentations at the 11th of the World Congress on Alternatives and Animal Use in the Life Sciences - Check out our activities!
IIVS News: IIVS Co-Publishes Article on Ocular Animal Model Alternatives
The human eye may be exposed to chemicals through various situations, such as accidental splashing…
IIVS News: IIVS to collaborate with RIFM to develop non-animal technologies for respiratory allergy
The Institute for In Vitro Sciences (IIVS) and the Research Institute for Fragrance Materials (RIFM)…
IIVS News: Validation of the 3D RSMN Assay
IIVS is excited to have taken part in the validation of the Reconstructed Skin Micronucleus…
IIVS News: IIVS e-News – October 2020
IIVS is pleased to announce that Allison Hilberer will participate in the OECD Test Guidelines…
IIVS News: IIVS, RIFM and Shiseido Partner to Transfer Non-animal Photosafety Tests
The Institute for In Vitro Sciences (IIVS) has entered into an agreement with Shiseido and…
IIVS News: Webinar : Use of Non-animal Skin Sensitization Methods
A recorded webinar on the “Use of Non-animal Skin Sensitization Methods” by IIVS’s Hans Raabe…
1 2 3 4 5 Next